Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 11/2021

16.04.2021 | Brief Report

Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial

verfasst von: Dolors Rodríguez-Pardo, María Dolores del Toro, Laura Guío-Carrión, Rosa Escudero-Sánchez, Marta Fernández-Sampedro, Miguel Ángel García-Viejo, María Velasco-Arribas, Laura Soldevila-Boixader, Magdalena Femenias, José Antonio Iribarren, María del Carmen Pulido-Garcia, María Dolores Navarro, Mayli Lung, Pablo S. Corona, Benito Almirante, Carles Pigrau

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 11/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate preoperative asymptomatic bacteriuria (ASB) treatment to reduce early-periprosthetic joint infections (early-PJIs) after hip hemiarthroplasty (HHA) for fracture.

Methods

Open-label, multicenter RCT comparing fosfomycin-trometamol versus no intervention with a parallel follow-up cohort without ASB. Primary outcome: early-PJI after HHA.

Results

Five hundred ninety-four patients enrolled (mean age 84.3); 152(25%) with ASB (77 treated with fosfomycin-trometamol/75 controls) and 442(75%) without. Despite the study closed without the intended sample size, ASB was not predictive of early-PJI (OR: 1.06 [95%CI: 0.33–3.38]), and its treatment did not modify early-PJI incidence (OR: 1.03 [95%CI: 0.15–7.10]).

Conclusions

Neither preoperative ASB nor its treatment appears to be risk factors of early-PJI after HHA. ClinicalTrials.​gov Identifier: Eudra CT 2016-001108-47
Anhänge
Nur mit Berechtigung zugänglich
Literatur
15.
Zurück zum Zitat Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–e25. https://doi.org/10.1093/cid/cis803 Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM et al (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 56:e1–e25. https://​doi.​org/​10.​1093/​cid/​cis803
16.
Zurück zum Zitat Glynn MKSJ (1984) The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res 185:151–154 Glynn MKSJ (1984) The significance of asymptomatic bacteriuria in patients undergoing hip/knee arthroplasty. Clin Orthop Relat Res 185:151–154
26.
Zurück zum Zitat Jameson SS, Jensen CD, Elson DW et al (2013) Cemented versus cementless hemiar- throplasty for intracapsular neck of femur fracture--a comparison of 60,848 matched patients using national data. Injury 44:730–734CrossRef Jameson SS, Jensen CD, Elson DW et al (2013) Cemented versus cementless hemiar- throplasty for intracapsular neck of femur fracture--a comparison of 60,848 matched patients using national data. Injury 44:730–734CrossRef
27.
Zurück zum Zitat Middleton RG, Uzoigwe CE, Young PS et al (2014) Peri-operative mortality after hemi- arthroplasty for fracture of the hip: does cement make a difference? Bone Jt J 96-B:1185–1191CrossRef Middleton RG, Uzoigwe CE, Young PS et al (2014) Peri-operative mortality after hemi- arthroplasty for fracture of the hip: does cement make a difference? Bone Jt J 96-B:1185–1191CrossRef
28.
Zurück zum Zitat Barbero JM, Montero E, Vallés A, Plasencia MA, Romanyk J, Gómez J (2016) Prosthetic joint infection in patients with hip fracture. Differences from infection of elective prosthesis. Rev Esp Quimioter 29:273–277PubMed Barbero JM, Montero E, Vallés A, Plasencia MA, Romanyk J, Gómez J (2016) Prosthetic joint infection in patients with hip fracture. Differences from infection of elective prosthesis. Rev Esp Quimioter 29:273–277PubMed
Metadaten
Titel
Role of asymptomatic bacteriuria on early periprosthetic joint infection after hip hemiarthroplasty. BARIFER randomized clinical trial
verfasst von
Dolors Rodríguez-Pardo
María Dolores del Toro
Laura Guío-Carrión
Rosa Escudero-Sánchez
Marta Fernández-Sampedro
Miguel Ángel García-Viejo
María Velasco-Arribas
Laura Soldevila-Boixader
Magdalena Femenias
José Antonio Iribarren
María del Carmen Pulido-Garcia
María Dolores Navarro
Mayli Lung
Pablo S. Corona
Benito Almirante
Carles Pigrau
Publikationsdatum
16.04.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 11/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-021-04241-2

Weitere Artikel der Ausgabe 11/2021

European Journal of Clinical Microbiology & Infectious Diseases 11/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.